FDA okays Iovance’s cell therapy for skin cancer, issues warning letter to China’s Sichuan Deebio
The United States Food and Drug Administration (FDA) has granted accelerated approval to Iovance’s cell therapy — A...
Impressions : 1382
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.